Glucagon-like peptide-1 and vitamin D: anti-inflammatory response in diabetic kidney disease in db/db mice and in cultured endothelial cells
Yes, it is available for research purposes in the U.S., but it is not FDA-approved for general medical use
In addition, the monthly prescription refill form provides an additional structured clinical interaction for providers to review the effectiveness of treatment from the standpoint of actual patient improvement and determine if a dose adjustment is needed
Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Green LA, Hochman JS, Jacobs AK, Krumholz HM , Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO
Medication safety: We only feature services that Cost: We took ongoing costs into account when selecting the services in this article